These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 8428107)

  • 1. Polymeric contrast agents for MR imaging of adrenal glands.
    Weissleder R; Wang YM; Papisov M; Bogdanov A; Schaffer B; Brady TJ; Wittenberg J
    J Magn Reson Imaging; 1993; 3(1):93-7. PubMed ID: 8428107
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of varying the molecular weight of the MR contrast agent Gd-DTPA-polylysine on blood pharmacokinetics and enhancement patterns.
    Vexler VS; Clément O; Schmitt-Willich H; Brasch RC
    J Magn Reson Imaging; 1994; 4(3):381-8. PubMed ID: 8061437
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inflammation: imaging with methoxy poly(ethylene glycol)-poly-L-lysine-DTPA, a long-circulating graft copolymer.
    Gupta H; Wilkinson RA; Bogdanov AA; Callahan RJ; Weissleder R
    Radiology; 1995 Dec; 197(3):665-9. PubMed ID: 7480736
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of gadolinium-DTPA and polylysine-gadolinium-DTPA--enhanced magnetic resonance imaging of hepatocarcinoma in the rat.
    Grandin C; Van Beers BE; Demeure R; Goudemant JF; Mottet I; Pringot J
    Invest Radiol; 1995 Oct; 30(10):572-81. PubMed ID: 8557496
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gd-DTPA adrenal gland enhancement at 1.5 T.
    Small WC; Bernardino ME
    Magn Reson Imaging; 1991; 9(3):309-12. PubMed ID: 1881248
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gd-DTPA-cascade-polymer: potential blood pool contrast agent for MR imaging.
    Adam G; Neuerburg J; Spüntrup E; Mühler A; Scherer K; Günther RW
    J Magn Reson Imaging; 1994; 4(3):462-6. PubMed ID: 8061448
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dynamic contrast-enhanced MR imaging of the upper abdomen: enhancement properties of gadobutrol, gadolinium-DTPA-polylysine, and gadolinium-DTPA-cascade-polymer.
    Adam G; Neuerburg J; Spüntrup E; Mühler A; Scherer K; Günther RW
    Magn Reson Med; 1994 Nov; 32(5):622-8. PubMed ID: 7808263
    [TBL] [Abstract][Full Text] [Related]  

  • 8. NMR imaging study of the pharmacodynamics of polylysine-gadolinium-DTPA in the rabbit and the rat.
    Van Hecke P; Marchal G; Bosmans H; Johannik K; Jiang Y; Vogler H; Van Ongeval C; Baert AL; Speck U
    Magn Reson Imaging; 1991; 9(3):313-21. PubMed ID: 1881249
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MR lymphography with a lymphotropic T1-type MR contrast agent: Gd-DTPA-PGM.
    Harika L; Weissleder R; Poss K; Zimmer C; Papisov MI; Brady TJ
    Magn Reson Med; 1995 Jan; 33(1):88-92. PubMed ID: 7891541
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glioblastoma multiforme: MR imaging at 1.5 and 9.4 T after injection of polylysine-DTPA-Gd in rats.
    Kornguth S; Anderson M; Turski P; Sorenson J; Robins HI; Cohen J; Rappe A; Markley J
    AJNR Am J Neuroradiol; 1990; 11(2):313-8. PubMed ID: 2156411
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Contrast-enhanced MR imaging of the kidneys and adrenal glands.
    Huch Böni RA; Debatin JF; Krestin GP
    Magn Reson Imaging Clin N Am; 1996 Feb; 4(1):101-31. PubMed ID: 8673709
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Magnetic resonance imaging detection of an experimental pulmonary perfusion deficit using a macromolecular contrast agent. Polylysine-gadolinium-DTPA40.
    Berthezène Y; Vexler V; Price DC; Wisner-Dupon J; Moseley ME; Aicher KP; Brasch RC
    Invest Radiol; 1992 May; 27(5):346-51. PubMed ID: 1582816
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Macromolecular intravenous contrast agent for MR lymphography: characterization and efficacy studies.
    Harika L; Weissleder R; Poss K; Papisov MI
    Radiology; 1996 Feb; 198(2):365-70. PubMed ID: 8596833
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A new macromolecule as a contrast agent for MR angiography: preparation, properties, and animal studies.
    Bogdanov AA; Weissleder R; Frank HW; Bogdanova AV; Nossif N; Schaffer BK; Tsai E; Papisov MI; Brady TJ
    Radiology; 1993 Jun; 187(3):701-6. PubMed ID: 8497616
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of a gadolinium-labeled cholesterol derivative as an organ-specific contrast agent for adrenal MR imaging.
    Mühler A; Platzek J; Radüchel B; Frenzel T; Weinmann HJ
    J Magn Reson Imaging; 1995; 5(1):7-10. PubMed ID: 7696812
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mannan-coated liposome delivery of gadolinium-diethylenetriaminepentaacetic acid, a contrast agent for use in magnetic resonance imaging.
    Kunimasa J; Inui K; Hori R; Kawamura Y; Endo K
    Chem Pharm Bull (Tokyo); 1992 Sep; 40(9):2565-7. PubMed ID: 1446380
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gd-DTPA-polylysine-enhanced pulmonary time-of-flight MR angiography.
    Böck JC; Pison U; Kaufmann F; Felix R
    J Magn Reson Imaging; 1994; 4(3):473-6. PubMed ID: 8061450
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gadolinium-ethoxybenzyl-DTPA, a new liver-specific magnetic resonance contrast agent. Kinetic and enhancement patterns in normal and cholestatic rats.
    Clément O; Mühler A; Vexler V; Berthezène Y; Brasch RC
    Invest Radiol; 1992 Aug; 27(8):612-9. PubMed ID: 1428739
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Functional hepatobiliary imaging with gadolinium-EOB-DTPA. A comparison of magnetic resonance imaging and 153gadolinium-EOB-DTPA scintigraphy in rats.
    Schmitz SA; Mühler A; Wagner S; Wolf KJ
    Invest Radiol; 1996 Mar; 31(3):154-60. PubMed ID: 8675423
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Improved method for in vivo magnetic resonance contrast media research.
    Schmiedl UP; Maravilla KR; Nelson JA
    Invest Radiol; 1991 Jan; 26(1):65-70. PubMed ID: 2022455
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.